- Home
- OPK vs HUMA Comparison
OPK vs HUMA Comparison
Compare OPK & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPK
- HUMA
- Stock Information
- Founded
- OPK 2007
- HUMA 2004
- Country
- OPK United States
- HUMA United States
- Employees
- OPK N/A
- HUMA N/A
- Industry
- OPK Biotechnology: Pharmaceutical Preparations
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- OPK Health Care
- HUMA Health Care
- Exchange
- OPK Nasdaq
- HUMA Nasdaq
- Market Cap
- OPK 1.0B
- HUMA 250.2M
- IPO Year
- OPK 1995
- HUMA N/A
- Fundamental
- Price
- OPK $1.40
- HUMA $1.47
- Analyst Decision
- OPK Buy
- HUMA Strong Buy
- Analyst Count
- OPK 4
- HUMA 8
- Target Price
- OPK $2.75
- HUMA $10.88
- AVG Volume (30 Days)
- OPK 1.9M
- HUMA 3.4M
- Earning Date
- OPK 11-06-2025
- HUMA 11-07-2025
- Dividend Yield
- OPK N/A
- HUMA N/A
- EPS Growth
- OPK N/A
- HUMA N/A
- EPS
- OPK N/A
- HUMA N/A
- Revenue
- OPK $664,029,000.00
- HUMA $818,000.00
- Revenue This Year
- OPK N/A
- HUMA N/A
- Revenue Next Year
- OPK $0.84
- HUMA $949.92
- P/E Ratio
- OPK N/A
- HUMA N/A
- Revenue Growth
- OPK N/A
- HUMA N/A
- 52 Week Low
- OPK $1.11
- HUMA $1.15
- 52 Week High
- OPK $2.04
- HUMA $6.77
- Technical
- Relative Strength Index (RSI)
- OPK 53.59
- HUMA 37.20
- Support Level
- OPK $1.34
- HUMA $1.38
- Resistance Level
- OPK $1.44
- HUMA $1.53
- Average True Range (ATR)
- OPK 0.04
- HUMA 0.09
- MACD
- OPK 0.00
- HUMA 0.02
- Stochastic Oscillator
- OPK 60.00
- HUMA 31.03
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.